IGF-1 LR3 is not appropriate for patients who are pregnant or breastfeeding, have active cancer or a cancer history (because IGF-1 stimulates cell growth broadly, including potentially malignant cells), have uncontrolled diabetes or diabetic retinopathy, or are under 21
It can help prevent metabolic syndrome, said Dr
While some findings are intriguing, they are far from conclusive, especially when it comes to human use
The emails were sent to two relevant recipient groups one group of current or former patients of the companys clinician-led weight management programme, and a second group of individuals who had opted in to receive marketing communications, said Voy
One study investigating these effects in obese mice discovered that administration of an NNMT blocker reduced insulin serum levels by 50-60% in the subjects